|
C17ORF63 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.237980E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.365100E-04 |
| Normal-vs-Stage2 |
5.627500E-04 |
| Normal-vs-Stage3 |
9.760200E-02 |
| Normal-vs-Stage4 |
1.000210E-01 |
| Stage1-vs-Stage2 |
1.985170E-01 |
| Stage1-vs-Stage3 |
1.196400E-01 |
| Stage1-vs-Stage4 |
2.774600E-01 |
| Stage2-vs-Stage3 |
2.128300E-02 |
| Stage2-vs-Stage4 |
4.621700E-02 |
| Stage3-vs-Stage4 |
9.231400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.596170E-03 |
| Normal-vs-AfricanAmerican |
5.019800E-03 |
| Normal-vs-Asian |
1.042180E-01 |
| Caucasian-vs-AfricanAmerican |
3.456400E-01 |
| Caucasian-vs-Asian |
2.869000E-01 |
| AfricanAmerican-vs-Asian |
1.192030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.882510E-03 |
| Normal-vs-Female |
7.217100E-03 |
| Male-vs-Female |
4.438800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.807300E-04 |
| Normal-vs-Age(41-60Yrs) |
3.636600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.819600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.519800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.143000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.991800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.891200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.080200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.640200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.328600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.662100E-02 |
| Classical-VS-Follicular |
1.166610E-01 |
| Classical-VS-Other |
6.146200E-01 |
| Classical-VS-Normal |
6.154200E-04 |
| Tall-VS-Follicular |
4.212200E-01 |
| Tall-VS-Other |
6.609600E-01 |
| Tall-VS-Normal |
3.328000E-01 |
| Follicular-VS-Other |
9.833600E-01 |
| Follicular-VS-Normal |
5.040100E-02 |
| Other-VS-Normal |
3.375200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.638100E-03 |
| Normal-vs-N1 |
3.574000E-01 |
| N0-vs-N1 |
1.146640E-01 |
|
|
